Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Creighton, Chad J  [Clear All Filters]
2013
Creighton CJ, Gibbons DL, Kurie JM. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res. 2013;5:187-95.
2014
Yang X, Zhang M, Ramos C, Durett A, Liu E, Dakhova O, Liu H, Creighton CJ, Gee AP, Heslop HE, et al. Closely-related T-memory stem cells correlate with in-vivo expansion of CAR.CD19-T cells in patients and are preserved by IL-7 and IL-15. Blood. 2014.
2015
Ozen M, Karatas OFaruk, Gullluoglu S, Bayrak OFaruk, Sevli S, Guzel E, Ekici ID, Caskurlu T, Solak M, Creighton CJ, et al. Overexpression of miR-145-5p Inhibits Proliferation of Prostate Cancer Cells and Reduces SOX2 Expression. Cancer Invest. 2015.
2018
Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PKwok-Shing, Jeong KJin, Tsang YHuen, Moreno D, Bhavana VHemanjani, et al. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep. 2018;25(5):1304-1317.e5.
2019
Kwon O-J, Zhang Y, Li Y, Wei X, Zhang L, Chen R, Creighton CJ, Xin L. Functional Heterogeneity of Mouse Prostate Stromal Cells Revealed by Single-Cell RNA-Seq. iScience. 2019;13:328-338.
2020
Kwon O-J, Choi JMin, Zhang L, Jia D, Li Z, Zhang Y, Jung SYun, Creighton CJ, Xin L. The Sca-1 and Sca-1 mouse prostatic luminal cell lineages are independently sustained. Stem Cells. 2020.
2022
Wei X, Zhang L, Zhang Y, Cooper C, Brewer C, Tsai C-F, Wang Y-T, Glaz M, Wessells HB, Que J, et al. Ablating Lgr5-expressing prostatic stromal cells activates the ERK-mediated mechanosensory signaling and disrupts prostate tissue homeostasis. Cell Rep. 2022;40(10):111313.
2023
Zhou Z, Jia D, Kwon O, Li S, Sun H, Roudier MP, Lin DW, True L, Morrissey C, Creighton CJ, et al. Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth. Oncogene. 2023.
Capik O, Gundogdu B, Tatar A, Sahin A, Chen F, Creighton CJ, Karatas OFaruk. Oncogenic miR-1825 promotes head and neck carcinogenesis via targeting FREM1. J Cell Biochem. 2023.
Kriseman ML, Tang S, Liao Z, Jiang P, Parks SE, Cope DI, Yuan F, Chen F, Masand RP, Castro PD, et al. SMAD2/3 signaling in the uterine epithelium controls endometrial cell homeostasis and regeneration. Commun Biol. 2023;6(1):261.
2024
Dunn TN, Cope DI, Tang S, Sirupangi T, Parks SE, Liao Z, Yuan F, Creighton CJ, Masand RP, Radilla LAlpuing, et al. Inhibition of CSF1R and KIT with pexidartinib reduces inflammatory signaling and cell viability in endometriosis. Endocrinology. 2024.